John Haanen

Netherlands Cancer Institute - Division of Molecular Oncology and Immunology

Amsterdam

Netherlands

SCHOLARLY PAPERS

4

DOWNLOADS

85

TOTAL CITATIONS

0

Scholarly Papers (4)

1.

An Update on Access to Novel Treatment for Metastatic Melanoma in Europe ­— a 2024 Survey of the European Melanoma Registry and the European Association of Dermato-Oncology

Number of pages: 12 Posted: 17 Sep 2024
Military Medical Academy of Belgrade, affiliation not provided to SSRN, Odense University Hospital, affiliation not provided to SSRN, Netherlands Cancer Institute - Division of Molecular Oncology and Immunology, affiliation not provided to SSRN, University Hospital Centre Zagreb, Medical University of Vienna, Clinical Center University of Sarajevo, Universitair Ziekenhuis Brussel, affiliation not provided to SSRN, affiliation not provided to SSRN, Aristotle University of Thessaloniki, The University of Manchester, University Hospital Zurich, Hospital Universitario Gregorio Marañón, Ovidius University of Constanta, Elbe Kliniken Buxtehude, Vilnius University, Institute of Oncology Ljubljana, University of Szeged, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Saints Cyril and Methodius University of Skopje, affiliation not provided to SSRN, Schleswig-Holstein University and University of Tübingen - Centre for Dermatooncology
Downloads 30 (935,157)

Abstract:

Loading...

melanoma - access to medicines - disparities - cancer care - immunotherapy - targeted therapy

2.

Real-World Data on Tolerability and Clinical Response of Cemiplimab in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Retrospective, Multicentre Cohort Study from the Netherlands

Number of pages: 34 Posted: 13 Jul 2023
Netherlands Cancer Institute, Radboud University Nijmegen - Radboud University Nijmegen, Utrecht University - University Medical Center (Utrecht), Netherlands Cancer Institute, Netherlands Cancer Institute, Netherlands Cancer Institute, Netherlands Cancer Institute, Radboud University - Radboud University Medical Center and Netherlands Cancer Institute - Division of Molecular Oncology and Immunology
Downloads 24 (974,723)

Abstract:

Loading...

cutaneous squamous cell carcinoma, cemiplimab, immunotherapy, locally advanced, metastatic

3.

Population Mortality in Advanced Melanoma Patients with and Without Response and Progression; Data from the Dutch Melanoma Treatment Registry

Number of pages: 20 Posted: 23 Nov 2022
Dutch Institute for Clinical Auditing, VU University Amsterdam - Department of Medical Oncology, Rode Kruis Ziekenhuis, Netherlands Cancer Institute - Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Maastricht University Medical Centre, Zuyderland Medical Centre, Isala Zwolle, University of Groningen - University Medical Center Groningen, Leiden University Medical Centre, Medisch Spectrum Twente, Medical Center Leeuwarden, Amphia Hospital, Maxima Medical Centre, Radboud University Nijmegen - Radboud University Medical Center, University of Ljubljana, Utrecht University - University Medical Center (Utrecht), Dutch Institute for Clinical Auditing and Leiden University - Leiden University Medical Center (LUMC)
Downloads 17 (1,051,189)

Abstract:

Loading...

relative survival, advanced melanoma, population mortality, older patients, response status, multi-state model

4.

OX40 Agonism Enhances Efficacy of PD-L1 Checkpoint Blockade by Shifting the Cytotoxic T Cell Differentiation Spectrum

Number of pages: 47 Posted: 15 Feb 2022
Leiden University - Department of Immunology, Leiden University - Department of Immunology, Leiden University - Department of Immunology, Delft University of Technology - Pattern Recognition and Bioinformatics, Leiden University - Department of Parasitology, Erasmus University Rotterdam (EUR) - Department of Pulmonary Diseases, Leiden University - Department of Immunology, Leiden University - Department of Immunology, Leiden University - Department of Immunology, Leiden University - Department of Immunology, Leiden University - Department of Immunology, Leiden University - Department of Immunology, Leiden University - Department of Infectious Diseases, Leiden University - Central Animal and Transgenic Facility, Leiden University - Department of Human Genetics, Leiden University, Medical Center (LUMC), Department of Pathology, Leiden University - Sequencing Analysis Support Core, University of Amsterdam - Department of Internal Medicine, Netherlands Cancer Institute - Division of Molecular Oncology and Immunology, Erasmus University Rotterdam (EUR) - Department of Pulmonary Diseases, Leiden University - Department of Immunology and Leiden University - Department of Parasitology
Downloads 14 (1,085,630)

Abstract:

Loading...